Imetelstat
Geron Corporation
['mds']
imetelstat yielded improvements in transfusion independence and hemoglobin in patients with notably transfusion dependent, non-del(5q) lower-risk relapsed/refractory myelodysplastic syndrome. #mds #asco23 | 
Home of the journal ONCOLOGY®, CancerNetwork® offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.